🏛️ Verified NIH Record • Updated 2026-05-26
Nasal Inhalation of Isopropyl Alcohol for the Treatment of Nausea in Patients With Cancer (NCT04181463)
🟡 Not Yet Recruiting Phase2 💊 Investigational Drug / Biologic Sponsor: M.D. Anderson Cancer Center
🩺 Plain-English Summary (8th-Grade Level)
The goal of this research study is to understand the effect of inhalation approaches in reducing nausea in cancer patients.
Who can join: To join this study, participants generally need to meet the listed inclusion criteria (6 items) and avoid the listed exclusions (7 items).
Location: M D Anderson Cancer Center — Houston, Texas
📋 "Do I Qualify?" — 1-Minute Self Screener
Instant ChecklistCheck every box below. If you can check all of them, you may meet the study's basic screening requirements (final eligibility is confirmed by the site team).
Usually NOT eligible if any of the following apply:
- Exclusion Criteria:
- Received anti-emetics in the last 30 minutes
- Received medical procedures (e.g. blood draws) which required exposure of isopropyl alcohol in the last 30 minutes
- Inability to inhale through nares (including recent upper respiratory infection)
- Known allergy to isopropyl alcohol
- Delirium (i.e., score \>= 7 on the Memorial Delirium Assessment Scale \[MDAS\])
- Have never been on anti-emetics during the course of the treatment here (anti-emetic naive)
🔍 Extracted verbatim from the official NIH eligibility criteria. Always confirm with the study coordinator.
📍 All Participating Trial Locations (1 Sites)
- M D Anderson Cancer Center — Houston, Texas
💰 Cost, Insurance & Patient Rights
- 100% Free Items: The investigational treatment and protocol-required procedures are supplied at zero cost by the sponsor.
- Routine Patient Care: Under federal law (ACA § 2709) and many state statutes, routine care costs are covered during participation.
- Voluntary Participation: You may withdraw at any time without affecting your standard medical care.